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Three factor H mRNA species of 4.3 kb, 1.8 kb, 
and 1.4 kb  are constitutively  expressed in  human 
liver. Having previously characterized full-length 
cDNA clones derived from the 4.3-kb and 1.8-kb 
factor mRNA, we  report  here  the  isolation  and  eu- 
caryotic  expression of full-length cDNA clones  cod- 
ing  for the  1.4-kb mRNA species. The  1266-bp  cDNA 
codes for a polypeptide of 330 amino acids and 
contains  two  polyadenylation  signals  and  a  short 
poly(A)+tail. The protein is composed of a leader 
peptide  followed  by  five  short consensus repeat  do- 
mains. It shows a hybrid structure with the last 
three domains being almost identical to the car- 
boxy-terminal  of  the classical 1 BO-kDa factor H mol- 
ecule  and  the  two  first  domains  representing  unique 
short  consensus  repeat  structures.  Eucaryotic 
expression  in COS7 cells revealed  two  polypeptides 
derived  from one cDNA clone  that  are also found  in 
human  serum.  Differences  between  the  cDNA clones 
within  the last three  domains  indicate  two  distinct, 
possibly allelic sequences that, in addition, differ 
from the  authentic  150-kDa  factor H sequence. 
Southern  blot results support  the  notion  that  the 
4.3-kb factor H and the 1.4-kb factor H-related 
mRNA are  transcribed from two  separate  but  highly 
homologous genes. 
Factor H, a glycoprotein of 150,000 Mr, is a regulatory 
protein of the complement  system  that  plays a key role 
in  the regulation of the alternative pathway. Factor H 
accelerates  the  dissociation of Bb from the C3  convertase 
C3b,Bb (1) and functions as a cofactor for factor I, a 
serine  protease  cleaving  C3b  into  inactive iC3b that  can 
no longer form the  C3  convertase by binding  factor B (2). 
The C3b  binding  site of factor H has been localized to  the 
N-terminal of the molecule (3). Previous studies have 
suggested that  factor H has  physiologic functions  other 
than  the regulation of alternative  pathway  C3 conver- 
tase. Factor H is capable of triggering the respiratory 
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burst in human peripheral monocytes (4) and inhibits 
the differentiation of peripheral B lymphocytes (5). It 
furthermore  promotes  the  release of factor I from B lym- 
phocytes (6). It has been  shown  that  factor H binds  to 
lymphocytes,  granulocytes, and monocytes by means of 
a receptor (7). A possible candidate  for  the  factor H recep- 
tor has been localized on B  lymphoblastoid cell lines (8). 
and more  recently,  another  protein  was isolated that may 
represent  the  same receptor (9). The  main production of 
factor H occurs in liver. Synthesis of factor H mRNA has 
also  been  described  for human peripheral blood mono- 
cytes  (1 0). the promonocyte cell line U937 (1  1).  and more 
recently  for human platelet  granules  (1 2). In  HUVEC4 and 
in  human  skin  fibroblasts,  the  synthesis of factor H could 
be enhanced by stimulation  with IFN-7 and TNF-a 
The  protein  structure of classical  factor Hgpl50 has been 
established by the isolation of overlapping cDNA clones 
and  is composed of 20 SCR of approximately 60 aa. Each 
SCR shows a characteristic framework of highly con- 
served  residues (1 6- 18).  The SCR feature is a character- 
istic of a structural  protein  superfamily  made  up of sev- 
eral C-like proteins  such as C-receptor  type 1, C4-binding 
protein, and decay  accelerating  factor,  and of non-C  pro- 
teins like factor XIII, IL-2R. and &glycoprotein I (19). 
Northern  blots of human liver RNA probed with  factor H 
cDNA fragments  show  three  different  constitutively ex- 
pressed mRNA species of 4.3  kb,  1.8  kb,  and  1.4  kb (20). 
We have previously shown by eucaryotic transfection 
studies that the 4.3-kb mRNA codes for the classical 
factor HgplSO and  the  1.8-kb mRNA codes  for a truncated 
form of 43  kDa present  in  serum (21). In this paper we 
report the isolation and characterization of factor H- 
related cDNA clones  transcribed  from  the  1.4-kb mRNA 
detected  in human liver. We show  that  this  transcript is 
in  its  C-terminal  part  (three SCR) almost  identical  to the 
sequence of the  factor Hgpl50 molecule characterized  from 
the  same individual,  but codes for a unique N-terminal 
consisting of two novel domains. Upon transfection  into 
COS7 cells, two polypeptides are recognized in culture 
supernatants by the mAb 3D11.7, directed to the C- 
terminal  part of factor H (22).  which  are  also  found  in 
human  serum.  Thus,  the  four  factor H-like proteins  de- 
(13-15). 
endothelial cells; factor HgplS0. 150-kDa factor H: cpm. counts per minute: 
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catalytic Bb peptide of the alternative pathway of complement activation. 
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tected  in  human  serum by polyclonal antifactor H anti- 
sera  are derived from  the  three mRNA species in liver. 
Preliminary  evidence  suggests  that  they  are  transcribed 
from  two  homologous genes. 
MATERIALS AND METHODS 
RNA preparation and cDNA synthesis. Total RNA was  extracted 
from a piece of normal,  nonlnfiltrated liver tissue, derived from one 
patient with liver carcinoma, according to the  guanidinium isothio- 
cyanate/CsCl  procedure (23). poly(A)+RNA was isolated with an oligo 
(dT) cellulose spin column  obtained  from Pharmacia LKB. Freiburg. 
FRG: 15-pg poly(A)+RNA was employed for cDNA synthesis using 
the kit  supplied by  BRL, Karlsruhe. FRG. 
expression vector CDMB. The cDNA was blunt-ended with T4- 
Construction and  screening of a cDNA library  in  the  eucaryotic 
polymerase and ligated to BstXI adaptors.  The ligated cDNA was size 
selected (>1 kb)  through a gradient of 5 to 20% potassium  acetate 
and cloned into  the  gradient purified BstXI cut vector CDM8 follow- 
ing  the protocol of Seed, (24,  25).  The  resultant  library of 300,000 
colonies was  screened with a ~~-(~~P]dATP-labeled DNA probe of 300 
bp derived from the  3’  end of the cDNA clone H46, hybridizing to 
the  4.3-kb  and  the  1.4-kb mRNA (20). 
Sequence  analysis. DNA sequencing  was performed by the di- 
deoxy chain  termination method 126) using  the  T7 polymerase se- 
quencing kit supplied by Pharmacia/LKB. dscDNA was directly 
sequenced in both directions  using  different oligonucleotides: two 
located 5’ and 3‘ of the BstXI cloning site within the CDM8 
vector (oCDM8- 1 /5’: CTGGCTAACTAGAGAAC and oCDM8-2/3’: 
GATCCTCTAGAGTCGC). and two additional oligonucleotide primers 
present  in  5’  and 3’ orientation  within  the cDNA insert  (underlined 
in Fig. 3). 
Northern blot analysis. One  microgram of poly(A)+RNA of human 
liver tissue was electrophoresed in a 1.2% agarose gel containing 
formaldehyde and  transferred to nylon membrane Hybond (Amer- 
sham, Braunschweig. FRG) by standard procedures (27).  The blots 
were hybridized with the  4.3-kb  insert of the  factor H full-length 
cDNA clone pFH4.3. the 1.8-kb insert of the full length cDNA 5’ 
clone pFH1.8 (Fig. 1). derived from the  1.8-kb  factor H transcript, 
and two cDNA probes of pFH1.4 containing  either SCR3-5 or 
Southern blot analysis. Fifteen  micrograms of restricted DNA of 
two human liver DNA preparations (one sample  was isolated from 
the same liver tissue used for cDNA library construction) were 
separated on  a 0.7%  agarose gel and  transferred to nylon membrane 
Hybond (28). Blots were hybridized with  the 3’HindIII/Pstl fragment 
present  in pFH4.3 and pFH1.4. 
Labeling of DNA probes  and  hybridization. Radioactive probes 
were  obtained by labeling the  fragments  with  LY-(~*P]~ATP according 
to the  random  priming procedure (29). Hybridization was performed 
at  a concentration of 5 X lo6 cpm-labeled fragment/ml of hybridi- 
zation solution,  and  washing of the blots by the method of Church 
and Gilbert (30). 
COS cell transfectfon. Transfection  was carried out by electro- 
poration using a Bio-Rad Laboratories  (Richmond, CA) gene  pulser 
and following the  recommendations of the  supplier. Activelygrowing 
COS7 cells  were harvested  with PBS/2 mM EDTA, washed twice in 
cold  PBS, and  resuspended  at a concentration of 1 X lo7 cells per rnl 
in ice-cold phosphate-buffered sucrose (272 mM sucrose. 7 mM 
sodium phosphate, pH 7.4. 1 mM MgCI2); 0.8 ml of cell suspension 
were mixed with 50 pg of  DNA in a prechilled electroporation  cuvette 
and stored  on ice for 10  min. Cells were pulsed  with 0.35 kV at  25 
pF and were then allowed to recover on ice for 10 min. Cells were 
gently resuspended in 10 ml of DMEM supplemented  with 10% FCS 
and seeded into  94 16-mm tissue  culture petri dishes. At 24  h,  the 
medium was  changed  to DMEM containing 1 x Nutridoma-HU (Boeh- 
ringer. Mannheim. FRG). The supernatants were harv&ted 72 h 
after  the  pulse,  concentrated 20-fold, and assayed  for the expression 
of factor H-related proteins by Western blot analysis. 
Deglycosylation. Five microliters of human  serum were incubated 
with 5 pl of endoglycosidase FIN-glycosidase F  (EC3.2.1.961 
EC3.2.2.18. Boehringer Mannheim) at  37°C for 24 h. The  extent of 
deglycosylation was  tested by loading 5 pl of the reaction on SDS/ 
PAGE under  nonreducing conditions followed by Western  blotting. 
SDS-PAGE and Western blotting. Eighty microliters of concen- 
trated  supernatant from COS cell transfectants  and 3 pl of human 
serum were  subjected to SDS-PAGE under  nonreducing conditions 
(31). Proteins  were blotted to nitrocellulose  (Schleicher and Schuell. 
Dassel. FRG) (32). Blots were quenched with  1 % (w/v) dried milk in 
PBS and  washed  with PBS. All antisera were diluted in 2% dried 
milk/PBS. Staining  was  carried  out with the mAb 3D11.7 (22)  and 
SCR1-2. 
peroxidase-conjugated anti-mouse IgG (Dakopatts. Copenhagen. 
Denmark) as second  antibody. following standard protocol (32). 
RESULTS 
A human liver cDNA library was  constructed  from a 
liver specimen of a single  individual,  resulting in 300,000 
primary colonies that were screened with the 300-bp 
EcoRVIPstI fragment of clone pFH4.3. a cDNA clone 
derived  from the  same cDNA library  encoding  classical 
factor HgplSO (21) (Fig. 1). The screen yielded six cDNA 
clones  with  inserts  approximately  1.2  kb  in size  possibly 
coding  for  the  1.4-kb mRNA. Analysis of the  clones by 
restriction  with  the  enzymes HindIII and EcoRV (Fig. 1) 
demonstrated that the three cDNA clones pFH1.4a,b,c 
were in the correct  orientation  for  eucaryotic  expression 
in COS7 cells,  whereas  the  clones  pFH1.4d,e,f  were  in 
the inverted  orientation.  Sequences of the 5’ and  3’  ends 
of all six cDNA clones  were  determined  using oligomers 
within  the CDM8 linker. All cDNA sequences coded for 
the same 5‘ untranslated  sequence,  varying  only in 
length.  The cDNA pFH1.4~  carried a n  extended 3‘  un- 
translated region of additional 340 bp that did not  hybri- 
dize  to the  1.4-kb  factor H mRNA in  human liver [data 
not  shown],  thus  having  been  added  artificially  during 
the cloning  procedure.  Two  clones,  pFH1.4a and 
pFH1.4b,  were  chosen  for complete DNA sequence  deter- 
mination (Fig. 2). The nucleotide and deduced aa se- 
quence of clones pFH1.4a and b in comparison with 
classical H cDNA is shown  in  Figure 3. pFH4.3 is a  full- 
length  factor Hgplso cDNA clone  isolated  from the  same 
liver library,  and  its  sequence  determined  for  the 5‘ and 
the  3’  ends  (21) (Fig. 3) is identical to the  factor H se- 
quence  determined by Ripoche et  al. (1 7). The  two  pFHl.4 
cDNA clones  were  found  to  vary  in  seven  bases,  resulting 
in  three aa substitutions [Fig. 3). Sequence  determination 
of the additional  four  full-length  pFHl.4 cDNA clones in 
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clones derived from the classical 4.3-kb factor H mRNA (pFH4.3). the 
Figure 1. Comparison of the restriction map of the full-length cDNA 
Hind111 site at the 5’ end and the PstI site at the 3’ end  belong  to the 
1.8-kb mRNA (pFH1.8). and the 1.4-kb factor H mRNA (pFH1.4). The 
linker sequence of the vector CDM8. The extent of the unique sequences 
at the 3’ end of pFH1.8 and  at the 5’ end of pFH1.4 is indicated below 
the restriction map. The sites for the following  enzymes are shown: H ,  
HindIII; B. BgIII: S ,  Smal; E. EcoRV;  P.  PuuII; Ps, PstI. 
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Figure 2. Sequencing strategy of cDNA clone pFHl.4a. The extent of 
the signal sequence. of the SCR domain structures. and of the 3’ untrans- 
Iated  region (3’UTJ is indicated  above the restriction map with the follow- 
ing enzymes: D, DraI; E. EcoRV; H. HindllI; P. Puuli.  Arrows  mark the 
the sequences obtained from M 1 3  subclones). 
extent and direction of the DNA sequence determination (with showing 
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of cDNA clones pFH 1.4a and b in  comparison  with 
FLgure 3. Nucleotide and deduced aa  sequence 
classical H cDNA pFH4.3. The ollgonucleotides 
used for sequence analysis. the PvulI restriction 
site  within SCR 5, and  the  second  poiyadenylation 
The  beginning of each individual SCR domain is 
signal used in the RNA templates are underlined. 
marked. In cases  where  the  base  exchanges  result 
in aa  substitutions,  both  amino  acids  are  shown. 
with  the  second  residue  corresponding  to  the  var- 
iant position in either  pFH1.4b or pFH4.3. 
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the divergent segments  demonstrated that two of them 
(pFH 1.4e and f)  are identical to pFH 1.4a  and the remain- 
ing two (pFH1.4~  and ) correspond to pFHl.4b.  These 
results  indicate that  the cDNA clones are derived from 
two distinct 1.4-kb factor H-like mRNA species repre- 
senting  either allelic or isotypic sequences. 
As expected from Northern blot (Fig. 4) and colony 
screening results, the pFH1.4 sequences are virtually 
identical to the 3’ end of the classical 4.3-kb factor H 
transcripts  in  754 nucleotides. Ten nucleotide exchanges 
are found when  comparing  with the  pFHl.4a cDNA lead- 
ing to two aa substitutions. No homology to  known  factor 
H sequences  was detected for the  512  bp of the 5’ half of 
the  pFHl.4 cDNA. 
The cDNA  of pFHl.4a is 1266 bp in  length and  has one 
open reading  frame of 994 bp encoding a polypeptide of 
330 aa.  The open reading  frame is followed  by 189  bp of 
a 3’ untranslated region that contains two polyadenyla- 
tion signals at nucleotide positions 1  1  1 1 and  124 1 and a 
short poly[A) tail.  The second polyadenylation signal  was 
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used in  all  our cDNA sequences [ 1.4 or 4.3  kb).  The coding 
frame  starts  after  76 bp of 5‘ untranslated  sequence  and 
is followed  by a short hydrophobic stretch of 18  aa of the 
signal  sequence. According to von  Heinje (33). the  mature 
protein starts with  glutamic acid (E). 
The polypeptide encoded by pFH1.4 is, like the other 
factor H proteins  gp150 and  p43,  a  member of the  struc- 
tural SCR superfamily.  The protein molecule consists of 
five SCR domains with domains 1 and 2 representing 
new sequences. In a Northern blot analysis the corre- 
sponding unique 5’ sequence hybridizes exclusively to 
the small 1.4-kb band (Fig. 4, Lane 4). No additional 
transcripts were detected in  human liver mRNA. Every 
SCR domain contains  four  cysteines at conserved sites 
such  that each domain is determined by two intrachain 
disulfide bonds. The predicted polypeptide mass of M ,  
35,800  contains two possible N-glycosylation sites at  aa 
positions 109  and  178 [Fig. 3). The two pFHl.4-encoded 
variants differ by three aa within domain 3. SCR 3 and 
4 of pFH1.4a are identical to the SCR domains 18  and 
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kb 1 2 3 4  1 2  3 4 5  k D o  
200 
4.3-e a 0 
poly(A)'RNA was  separated on  an  agarose/formaldehyde gel. transferred 
Figure4. Northern blot of poly(A)'RNA from human liver: 1 ~g of 
to nylon membrane. and hybridized with the full-length pFH4.3 rDNA 
insert (lane I ] .  the full-length pFH1.8 rDNA insert (lane 2). a pFH1.4 
rDNA probe containing SCK 3-5 (lane 3). and a pFH1.4 cDNA probe 
containing SCR 1-2 (lane 4). which is sperific  for  the  1.4-kb  factor H 
mRNA sprries. 
19.  respectively, of factor Hgpl501 while SCR 5 corresponds 
to SCR 20  of factor Hgp150 with  the exception of two aa. 
Interestingly, the homology of pFHl.4 to pFH4.3 se- 
quences  starts  exactly  with SCR domain 3. 
pFH 1.4  codes  for  two  factor  H-related  proteins  present 
in  human  sera.  The  plasmid CDM8 used  for  constructing 
the cDNA library is a high  efficiency  eucaryotic  expres- 
sion  vector  (25). We directly  introduced DNA  of two cDNA 
clones pFH 1.4a  and pFH 1.4b  into COS7 cells by electro- 
poration.  The  supernatants  were  then  tested  for  the  en- 
coded proteins by Western blot analysis  using  an  anti- 
body directed  against  the  C-terminal of factor Hgf'150 (22). 
Interestingly, pFH 1.4a  and b both code  for two  proteins 
of 36.000 and  43,000 M, (Fig. 5a. lanes 1 and 2). The 
same two bands  are  also  detected  in  human  serum (Fig. 
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transfectants: 3 pl of normal  human  serum  and 8 0  P I  of 20-fold ronrrn-  
Figure5 Western blot analysis of factor H expression. A) COS cell 
tratcd  supernatants of the  individual  transfertion  assays  were  subjected 
to SDS/PAGE under  nonreducing  conditions  and  then  analyzed by West- 
ern  blotting  with  the  monoclonal  antifartor H antibody  3DI  1.7. Lane I :  
COS cells  transfected  with  pFH1.4a: lane 2: COS rclls transferted  with 
pFH1.4b: lanes 3 and 4: COS cells  transfected  with  the  vertor CDMR: 
lane 5: human  serum.  The  mAb  3DI  1.7  also  deterts  a  55-kDa  matcrial 
5a, lane 5). These results demonstrate that the mAb in COS cell culture supernatants probably derived from the Nufridoma 
3 ~ 1  1.7 is directed against an epitope present in SCR medium. R )  Glycosylation of fartor H proteins: 5 pl of endoglyrosidase F/ 
18-20. 
N-glyrosidase F-treated human serum (lanes I and 2)  and 2.5 pl of 
The  finding  that  one cDNA clone  encodes  two polypep- were  stained  with  the  mAb  3D1 1.7. Lanes 3 and 4 were stained with a 
untreated  human  serum (lanes 2 and 4 )  were  analyzed. Lanes I and 2 
tides could be explained by  different glycosylation forms polyclonal antibody to ij2-glyroprotein I a s  a positive rontt-01 for th r  
due to the  presence of two N-glycosylation sites  within 
deglyrosylation  procedure  (34). 
the pFH1.4 protein sequence. Treatment with endogly- 
cosidase FIN-glycosidase  F  (Fig. 5b)  and N-glycosidase  F 
alone  (data not shown)  decreased  the  molecular  mass of 
both,  the  43-kDa  and  the  36-kDa  peptides  leading  to  one 
molecule of 33 kDa. The 43-kDa peptide was reduced 
gradually  first  to 36 kDa and  finally  to 33 kDa (data  not 
shown].  These  results  indicate  that  the  43-  and  36-kDa 
molecules are glycoproteins  with  different  degrees of gly- 
cosylation  probably  corresponding  to  the  two glycosyla- 
tion sites  present  in  each molecule. 
The two  N-terminal SCR domains  specific  for  the  trans- 
lation  product of pFH 1.4  show low homology to  known 
human SCR-composed proteins (Fig. 6). Interestingly, 
these new SCR domains display the highest degree of 
homology to SCR 6 and 7 of classical  factor Hg1,150 (40%) 
(1 7). followed by the  domains 1 and 2 of &-glycoprotein I 
(32%)  (34).  the SCR 15  and  16 of the  human  complement 
C3b/C4b  receptor CR1 (30%) (35-37)  and  repeats 1 and 
2 of factor XllI (25%) (38). The  second SCR of the  pFHl.4 
protein has a significant homology of 23% to the SCR- 
like structure of human thyroid  peroxidase (39). 
B cause the cDNA sequences  derived  from  the  4.3-kb 
and  the  1.4-kb mRNA species  differ  within  the  shared 3'
region in a PuuII recognition sequence,  human  genomic 
DNA was  restricted  with PuuII and hybridized with the 
shared 3' fragment (HindIIIIPstI). All individuals ana- 
lyzed show  two  fragments (Fig. 7,  lanes 1-6). Otherwise, 
in several additional restriction digests tested (BamHI. 
TaqI. BglII, EcoRV. and HindllI). this probe  detects  only 
one  band (Fig. 7,  lanes 7 and 8 for HindIII). indicating 
high  sequence  similarity  being  also  reflected  at  the  gene 
organization. 
DISCUSSION 
We have  isolated cDNA clones  derived from the  small 
1.4-kb mRNA of the  three  factor H-like mRNA species 
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the factor H-related polypeptide. The se- 
Figure6.  The SCR domain  structure of 
quences of the SCR repeats  are  aligned us- 
ing  the  pattern of Perkins  et  al.  (18).  Con- 
served  residues  are  boxed.  The  upper  panel 
shows  the  intramolecular homology in the 
SCR domains of the  factor  H-related poly- 
cies. The homology search was performed 
peptide  encoded  by the 1.4-kb mRNA spe- 
using  the  Martinsried  Institute  Protein  Se- 
quences data bank. Only sequences with 
homology > 23%  are  shown In this  compar- 
ison. 
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code  for  the factor  H  4.3-kb and I .4-kb mRNA species: 15 pg  of restricted 
Figure 7. Southern blot analysis  indicates that highly  similar  genes 
human DNA of two  individuals  was  separated on a  0.7%  agarose gel and 
transferred  to  nylon  membrane.  Blots  were  hybridized  with  the 3' Hindlll/ 
Pstl  fragment  present  in  pFH4.3  and  pFHl.4.  Restriction  enzymes  were 
used a s  follows: lanes 1 and 2: PuuIl/HamHI: lanes 3 and 4: PuulI/Bglll: 
lanes  5 and 6: Puull: lanes  7 and 8: Hindlll. 
present  in  human  liver  that  encode a n w  factor  H-related 
protein.  The  protein is related  to  the  C-terminal of the 
classical  factor HK,,150 molecule because  it  shares  the  last 
three SCR domains  with  factor H,,p150 and  contains  two 
SCR domains that appear to be unique for the small 
protein.  The  translation  product is provisionally  named 
factor Hrr36. The hybrid nature of the  1.4-kb  factor H-like 
mRNA-encoded polypeptide is supported by the isolation 
of six independent, functional full-length cDNA clones 
containing  these  domains. Moreover,  it is interesting  to 
observe  that  the  aa  sequence of the  new  domains i joined 
in frame  at a SCR boundary of the following three  clas- 
sical C-terminal domains. Northern blot data, obtained 
TABLE I 
Comparison  ofthe  human  short-factor  H-related  transcript  fpFH1.4) 
with  the.full-leng?h  classical  murine.factor  H  sequence  (4.3  kbjand 
the cDNA 13GJ. deriued.from a shortfactor  H-related  transcript in 
the  mouse" 
Homology to Mousf Factor H cDNA ($1 
pFH I .4 13c1 4.3 kb 
aa bD aa bD 
SCR 1 81.8 75.8 
SCR 2  77.5 70.  
SCR 3 51.6 40.0  72.8  60.7 SCR 18 
SCR 4  80.4  76.8 80.7 75.4 SCR 19 
SCR 5 62.1  48.4 60.5 46.8 SCR 2 0  
and  the SCR 16-20  indicate  the  C-terminal SCR encoded by the  4.3-kb 
On the right the SCR domains of the  clone pFH 1.4  are  numbered. 
mouse transcript. The comparison was done for both the aa and the 
nucleotide  (bp)  sequences. 
with  subfragments,  confirm  that  the  sequence of pFHl.4 
SCRl  and 2 are linked  to SCR 18-20  in  the  1.4-kb mRNA 
species. 
The two  N-terminal  factor H,,,,,-specific  SCR domains 
show low homology to two  consecutive  units  in  known 
human SCR-composed proteins (Fig. 6). This finding 
might  indicate  that  the  two SCR structures form  a  func- 
tional domain or may be explained by the duplication 
process  the  genes  have  undergone.  The  structure of fac- 
tor H gene of man  (40)  and  mouse  (41)  shows a  grouping 
of SCR/exons  in  pairs,  with SCR 6 and 7 of the  4.3-kb 
mRNA being  one  pair. 
Transient  expression of pFHl.4a  and pFH 1.4b  shows 
that  the cDNA clones  represent  viable  transcripts of the 
1.4-kb  factor H-like mRNA of human liver. We were  able 
to  demonstrate  that  both  small  factor H-like  polypeptides 
detected  in  human  sera  with  either polyclonal factor H 
antisera or with the mAb 3D11.7 are encoded by one 
mRNA.  We could demonstrate  that both serum  proteins 
are glycosylation products of a  33-kDa polypeptide. Sim- 
ilar  results  have  been  described  with isolated  43-kDa and 
36-kDa  polypeptides  (42).  The  calculated  size of M, 
36.000 for the pFH 1.4-encoded  protein is in  agreement 
with  the  estimated  m.w. of 38,000 for the  33-kDa ungly- 
cosylated polypeptide when run under reducing condi- 
tions (42). The finding that this novel factor H-related 
molecule is also  arranged  in SCR units might  point  to  a 
role in  complement  regulation. Although  to date  the  func- 
tional  significance of the  repeating  units is not known,  it 
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has been  shown  that  many of the complement  proteins, 
built  up of SCR domains,  interact  in  some way with  either 
C3b  or  C4b.  The  binding  site of factor  H  to  C3b is located 
on  the  N-terminal (SCR 1-7) of factor HRp150. This region 
is shared by the  truncated  form of factor Hp43 encoded by 
the 1.8-kb mRNA (17.  21).  The  highest  degree of homol- 
ogy of the two novel SCR domains of the  pFHl.4 protein 
to the SCR domains 6 and 7 of factor Hgpl50 and Hp43 
might  be significant  for  the  function of this  new  factor 
H-related protein,  moreover,  inasmuch as it is coupled  to 
a C-terminal identical to the one of factor Hgpl50. The 
pFHl.4-derived factor H-related proteins isolated from 
human  sera  have been  shown  not  to  exert  complement- 
regulatory  functions  known  to  be  associated  with  classi- 
cal  factor  H  when  tested  for  activity  in  the  dissociation 
of C3bBb complexes or as cofactor  for  the cleavage of 
C3b by factor I (42).  They might share  some  unknown 
function with the classical factor Hgpl5O carried by the 
common SCR 18-20  but possibly modified by the  pres- 
ence of the novel N-terminal  structure. It is conceivable 
that  the pFH 1.4-encoded  polypeptides  might  also  bind  to 
the  factor H receptor and compete  with  factor HRplso as 
only  factor H of a certain  conformation, fb2, was  able to 
bind to the  factor H receptor of Raji cells  (43).  Alterna- 
tively, the two  N-terminal SCR of factor Hre36 might  have 
a n  additional  new  function  not fulfilled  by factor Hgpl5O. 
A third  hypothesis would propose that  the combination 
of the two  pFH1.4  specific SCR with  the  known  three- 
factor H SCR 18-20 would result  in a protein  with novel 
functional  activities  not  overlapping  with  the bioactivity 
of factor Hgp150. 
With  regard  to the  functional  importance of factor Hre36. 
it was of interest  to  learn  that a similar molecule evolved 
among the mouse factor H-like proteins (44) (Table I). 
Several  factor H-related transcripts  have  been  character- 
ized in  mouse liver that  have  not  been detected in  human 
liver mRNA. Nucleotide and aa sequence  comparison of 
our  factor H-related  clone pFHl.4b  with  the  mouse  clone 
13G1 and classical  mouse  factor H (4.3  kb)  shows a high 
homology between the two  factor H-related sequences of 
both  species,  with  the polypeptide sequence  being  more 
conserved than  the nucleotide  sequence.  The cDNA 
13G1,  like  pFH1.4,  codes  for  two  unique  N-terminal SCR 
domains coupled to three domains homologous to the 
carboxy  terminal of murine  factor Hgpl50 (SCR 19,  19,  20) 
also encoded by a 4.3-kb mRNA species.  Increased diver- 
gence is observed  for SCR 3 where  the  murine polypeptide 
contains  a  second SCR 19 homologous domain  instead of 
SCR 18, and in the last SCR 5. Interestingly, whereas 
human factor HrrS6 shares the carboxy terminal three 
SCR sequences with factor HgplSO, the mouse 13G1-en- 
coded protein has a  carboxy  terminal  that is homologous 
with  but  quite  divergent  from  the  murine  factor H,pl,o. 
The  characterization of the  three  factor H-related tran- 
scripts detected in human liver by cDNA cloning and 
eucaryotic  expression  leads  to  the  question  whether  these 
mRNA are derived  from one  gene  representing  alterna- 
tively spliced H gene  transcripts.  Previous  studies  have 
provided convincing  evidence  that  both  the  4.3-kb  and 
the  1.8-kb  factor H mRNA are  transcribed  from  the  same 
factor H gene  (17,  21).  The  results  reported  here  for  the 
1.4-kb  factor H-related transcript,  however,  indicate  that 
they  are  transcribed  from  another  gene(s).  First,  pFHl.4 
differs  from  the  4.3-kb  and  1.8-kb  transcripts  in  the 5' 
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untranslated region, which  points  to  separate  transcrip- 
tion start  sites.  The notion that  1.4-kb  and 4.311.8-kb 
mRNA synthesis is controlled  independently is supported 
by the  finding  that  the  1.4-kb  factor H-related transcript 
is only  detected  in human liver mRNA, whereas  the  4.3- 
kb and 1.8-kb mRNA species  are  concomitantly ex- 
pressed in other tissues (13, 45, 46). Second, pFHl.4 
sequences  overlapping  with  the  4.3-kb  transcript  are not
identical  to this  sequence as determined  from the  same 
liver  library.  The  restriction  enzyme PuuII, which  cleaves 
only in  the 3' sequence of the  pFHl.4alb (SCR 5, Fig. 3), 
is absent in  4.3-kb derived  clones. Moreover, the isolation 
of two distinct cDNA encoded by the  1.4-kb mRNA spe- 
cies  both  differing  from the  4.3-kb  transcript  exclude  an 
explanation of allelic  differences. 
Southern blot results  obtained  from  human genomic 
DNA restricted  with PuuII and hybridized  with the  shared 
3' fragment (HindIIIIPstI) show two fragments (Fig. 7, 
lanes 1-6). The  results  point  to  at  least  two  genes  in  the 
human genome, one coding for the 4.3-kb and 1.8-kb 
factor H transcripts,  and a  second  one coding for  the  1.4- 
kb  factor H-related mRNA. 
In the  future,  the isolation of the  gene(s) coding  for the 
1.4-kb  transcript will resolve the question  whether  the 
two  kinds of pFH1.4 cDNA clones are derived  from  two 
discrete loci or  whether  they  represent allelic sequences. 
Acknowledgments. We thank Dr. Erik  Bottger, Medi- 
zinische  Hochschule  Hannover,  for  his  helpful  comments 
on preparing the CDM8  cDNA library, Dr. G. Arnold, 
Genzentrum,  Munchen,  for  synthesizing  the oligonucle- 
otides, Dr. A. Braun  for  his  support  in  the deglycosylation 
experiments, and S. Person for excellent technical as- 
sistance. G. Messer is kindly  acknowledged for  his  help 
in  using  the  Martinsried  Institute  Protein  Sequences  data 
bank. 
REFERENCES 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
Whaley. K., and S .  Ruddy. 1976. Modulation of the alternative 
Pangburn, M. K. ,  R. P. Schreiber. and H. J. Muller-Eberhard. 1977. 
complement  pathway by BlHglobulin. J .  Exp. Med. 144:J  147. 
demonstration of a n  absolute  requirement  for  the  serum  protein 01H 
Human  complement  C3b  inactivator:  isolation.  characterization  and 
Alsenz, J.. J. D. Lambris, T. F. Schulz, and M. P. Dierich. 1984. 
for  cleavage of C3b  and  C4b  in  solution. J. Exp. Med.  146:257. 
cofactor  activity  for  factor I in the  38-kDa  tryptic  fragment of factor 
Localization of the complement-component-C3b-bindingsite and  the 
Schopf R. E., K. P.  Hammann, 0. Scheiner. E.". Lemmel, and M. 
H. Biochem. J. 224:389. 
P. Dierich. 1982. Activation of human monocytes by both human 
@1H and  C3b.  Immunology  46:307. 
Tsokos, G .  C., G .  Inghirami. C. D. Tsoukas, J. E. Balow. and J. D. 
Lambris. 1985.  Regulation of immunoglobulin  secretion by factor H 
Lambris, J. D., N. J. Dobson, and G .  D. Ross. 1980. Release of 
of human  complement.  Immunology  55:419. 
endogenous  C3b  inactivator  from  lymphocytes  in  response to trig- 
geringmembrane  receptors  for /31H globulin. J. Exp .  Med.  152:  1625. 
Schmitt. M., H.-H. Mussel, K.  P.  Hammann, 0. Scheiner, and M. P. 
Dierich. 1981. Role of B1H for  the  binding of C3b-coated  particles to 
Lambris, J. D., and G .  D. Ross. 1982. Characterization of the  lym- 
human lymphoid and  phagocytic cells.  Eur. J. Irnmunol. J 1:739. 
phocyte membrane receptor for factor H ( P l H  globulin] with a n  
antibody  to  anti-factor  H  idiotype. J. Exp. Med. 155: 1400. 
Erdei. A.. and R. B. Sim. 1987.  Complement  factor  H-binding  protein 
of Raji cells and  tonsil  B  lymphocytes.  Biochem. J .  246:  149. 
Whaley. K. 1980. Biosynthesis of the  complement  components  and 
the  regulatory  proteins of the  alternative  complement  pathway by 
human  peripheral blood monocytes. J. Exp. Med.  J51:501. 
Malhorta. V., and R. B. Sim. 1985. Expression of complement  factor 
H on the cell surface of the  human monocyte cell line  U937. Eur. J .  
Devine D. V., and W. F. Rosse. 1987. Regulation and activity of 
Immund.  17:935. 
platelet-bound  C3  convertase of the  alternative  pathway of cornple- 
3196 A FACTOR H-LIKE PROTEIN IS ENCODED BY THE 1.4-kb mRNA 
13. Brooimans R. A.. P. S. Hiemstra, A. A. J. van der Ark, R. 8. Sim, 
ment by platelet  factor H. Proc. Natl. Acad.  Sci. USA 84~5873. 
L. A. van Es, and M. R. Daha. 1989.  Biosynthesis of complement 
factor H by umbilical vein endothelial cells. Regulation by T cell 
14. Katz, Y., and R. C. Strunk. 1989. IL-1 and tumor necrosis factor. 
growth  factor  and IFNy. J .  Immunol. 142~2024. 
Similarities  and  differences in stimulation of expression of alterna- 
tive pathway of complement  and IFN@,/IL-6 genes  in  human  fibro- 
15. Ripoche. J., J. A. Mitchell, A. Erdei. C. Madin, B. Moffatt, T. 
blasts. J .  Irnmunol. 124~3862. 
Mokoena, S.  Gordon, and R. B. Sim. 1988. Interferon-y induces 
synthesis of complement alternative pathway proteins by human 
endothelial cells in  culture. J. Exp. Med. 168:1917. 
16. Reid, K. B. M., D. R. Bentley. R. D. Campbell, L. P. Chung, R. B. 
Sim, T. Kristensen, and B. F. Tack. 1986. Complement system 
proteins  which  interact  with  C3b or C4b. A superfamily of structur- 
17. Ripoche, J.. J. D. Anthony. T. J. R. H a m s ,  and R. B. Sim. 1988. 
ally related  proteins.  Immunol.  Today 7:230. 
The complete amino  acid  sequence of human  factor H. Biochem. J .  
249:593. 
18. Perkins, S. J., P. I. Hans, R. B. Sim, and D. Chapman. 1988. A 
study of the  structure of human complement  component  factor H by 
Fourier  transformed  infrared  spectroscopy  and  secondary  structure 
averaging  methods.  Biochemistry  27:4004. 
19. Reid, K. B. M.. and A. J. Day. 1989.  Structure-function  relationships 
of the complement  components.  Immunol.  Today 10: 177. 
20. Schwaeble. W.. J. Zwirner. T. F. Schulz. R. P. Linke, M. P. Dierich, 
and E. H. Weiss. 1987.  Human  complement  factor H: expression of 
an  additional  truncated  gene  product of 43  kDa in  human liver. Eur. 
J .  Immunol.  17:1485. 
21. Estaller, C.. W. Schwaeble, M. P. Dierich, and E. H. Weiss. 1990. 
Human  complement  factor H: two  factor H serum  proteins  are d rived 
22. Fontaine, M..  M. J. Demares, V. Koistinen. A. J. Day. Ch. Dav- 
from alternatively spliced transcripts.  Eur. J. Immunol. In press. 
rinche, R. B. Sim. and J. Ripoche. 1989.  Truncated  forms of human 
complement  factor H. Biochem. J .  258:927. 
23. Chirgwin. J. M., A. E. Przsybyla. R. J. MacDonald, and W. J. Rutter. 
1979. Isolation of biologically active  ribonucleic  acid  from  sources 
enriched  in  ribonuclease.  Biochemistry 18:5294. 
24. Aruffo. A.. and B. Seed. 1987. Molecular cloning of a CD28 cDNA 
by a high-efficiency COS cell expression  system. Proc. Natl. Acad. 
Sci. USA 84:8573. 
25. Seed. B. 1987. An LFA-3 cDNA encodes  a  phospholipid-linked  mem- 
brane  protein homologous to  its  receptor CD2. Nature  329~840. 
26. Sanger, F., S. Nicklen. and A. R. Coulson. 1977. DNA sequencing 
with  chain-terminating  inhibitors. Proc. Natl. Acad.  Sci. USA 
74:5463. 
27. Maniatis. T.. E.  F. Fritsch. and J. Sambrook. 1982. Molecular 
Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory 
Press. Cold Spring  Harbor, NY. 
28. Southern, E. 1975. Detection of specific sequences among DNA 
fragments  separated by gel electrophoresis. J .  Mol. Biol. 98:503. 
29. Feinberg. A. P.. and B. Vogelstein. 1983. A technique  for  radiola- 
tivity. Anal.  Biochem. 132:6. 
beling DNA restriction endonuclease  fragments  to high specific ac- 
30. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. 
Natf. Acad. Sci. USA 81:1991. 
31. Laemmli, U. K., and M. Favre. 1970. Maturation of the head of 
bacteriophage  T4.  Nature 227:680. 
32. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic 
transfer of proteins  from polyacrylamid gels to nitrocellulose sheets: 
procedure  and  some  applications. Proc. Natl. Acad.  Sci. USA 
76:4350. 
33. von Heijne G. 1987. Sequence Analysis in Molecular Biology. 
Treasure Troue or  Trivial  Pursuit? Academic Press, New York. 
34. Lozier, J., N. Takahashi, and F. W. Putnam. 1984. Complete amino 
acid sequence of human  plasma @2-glycoprotein I. Proc. Natl. Acad. 
Sci. USA 81:3640. 
35. Holers, V. M., J. L. Cole. D. M. Lublin, T. Seya, and J. P. Atkinson. 
1985. Human C3b-and C4b-regulatory proteins: a new multigene 
family. Immunol. Today 6: 188. 
36. Kristensen, T.. P. D'Eustachoi, R. T. Ogata, L. P. Chung, K. B. M. 
Reid, and B. F. Tack. 1987.  The  superfamily of C3b/C4b-binding 
37. Klickstein, L. B.. W. W. Wang, J. A. Smith, J. H. Weis. J. G. Wilson, 
proteins. Fed. Proc. 46:2463. 
and D. T. Fearon. 1987. Human C3b/C4b receptor [CRl). Demon- 
stration of long homologous repeating  domains. J. Exp. Med. 
165: 1095. 
38. Ichinose, A., B. A. McMullen. K. Fujikawa, and W. Davie. 1986. 
Amino acid sequence of the  b  subunit of human  factor XIII. a protein 
composed of 10  repetitive  segments.  Biochemistry  25:4633. 
39. Kimura, S., T. Kotani, 0. W. McBride, K. Umeki, K. Hirai, T. 
Nakayama, and S. Ohtaki. 1987.  Human thyroid peroxidase: com- 
plete cDNA and protein  sequence,  chromosome  mapping,  and  iden- 
tification of two alternatively  spliced mRNAs. Proc. Natl. Acad.  Sci. 
USA 84:5555. 
40. McAleer. M. A.. J. Ripoche, 0. Dominguez, W. Schwaeble, and R. 
B. Sim. 1989.  Partial  gene  structure  for  human  factor H includes an 
alternative splice region. Seventh  International  Congress of Immu- 
41.  Vik, D. P., J. B. Keeney, P. Munoz-Canoves, D. D. Chaplin, and B. 
nology. Gustav  Fischer  Stuttgart New York. p. 24-17  (Abstr.). 
F. Tack. 1988.  Structure of the  murine  complement  factor H gene. 
J. Biol. Chem.  263:  16720. 
42. Timmann, C., M. Leippe, and R. D. Horstmann. 1991, Two major 
different glycosylation forms of a  single protein with no factor H-like 
serum  components  antigenically  related to complement  factor H are 
complement regulatory functions. J. Immunol. In press. 
43. Ripoche, J.. A. Erdei. D. Gilbert, A. A1 Salihi. R. B. Sim. and M. 
Fontaine. 1988. Two populations of complement  factor H differ  in 
44. Vik, D. P..  P. Munoz-Canoves. H. Kozono. L. G. Martin, B. F. Tack, 
their  ability  to bind to cell surfaces.  Biochem. J .  253:475. 
and D.  D. Chaplin. 1990. Identification and sequence analysis of 
four  complement  factor H-related transcripts  in mouse liver. J. B i d  
45. Katz. Y., and R. C. Strunk. 1988.  Synthesis  and regulation of com- 
Chem.  265:3193. 
46. Schwaeble, W., H. Schwaiger, M. Schweiger. and M. P. Dierich. 
plement  factor H in  human  skin  fibroblasts. J .  Immunol. 141:559. 
species  for  complement  factor H in human  endothelial cells. Eur. J .  
1991.  Interferon-y  induces the  synthesis of the  three major mRNA 
Biochem. In press. 
